UK markets closed

ABIONYX Pharma SA (ABNX.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
1.0660+0.0160 (+1.52%)
At close: 04:55PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 33.75M
Enterprise value 36.08M
Trailing P/E 9.94
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.35
Price/book (mrq)7.04
Enterprise value/revenue 7.84
Enterprise value/EBITDA -11.28

Trading information

Stock price history

Beta (5Y monthly) -0.12
52-week change 3-39.45%
S&P500 52-week change 323.57%
52-week high 32.1600
52-week low 30.9100
50-day moving average 31.0471
200-day moving average 31.1837

Share statistics

Avg vol (3-month) 353.22k
Avg vol (10-day) 325.54k
Shares outstanding 532.15M
Implied shares outstanding 632.15M
Float 8N/A
% held by insiders 131.20%
% held by institutions 15.02%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -76.09%
Operating margin (ttm)-47.41%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)4.6M
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)-5.70%
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-3.5M
Diluted EPS (ttm)-0.1100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)N/A
Total cash per share (mrq)N/A
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)N/A
Book value per share (mrq)0.17

Cash flow statement

Operating cash flow (ttm)-3.7M
Levered free cash flow (ttm)N/A